Evidence map›Paper›PMID 27605022›Full record

ReviewGenome medicine2016

Recent advances in malaria genomics and epigenomics.

Sebastian Kirchner, B Joanne Power, Andrew P Waters

Open access · goldAbstract readReview
In one paragraph

Review in Genome medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
7.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Exploring the relationship betweenThe Pan African medical journal · 2024
    Article
  6. Review
  7. Update and elucidation ofComputational and structural biotechnology journal · 2022
    Article
  8. Article
  9. Home Sweet Home:Frontiers in cellular and infection microbiology · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Host-Malaria Parasite Interactions and Impacts on Mutual Evolution.Frontiers in cellular and infection microbiology · 2020
    Review
  14. Review
  15. Review
  16. Review
  17. Unraveling the 3D genome of human malaria parasites.Seminars in cell & developmental biology · 2019
    Review
  18. Article
  19. Article
  20. Immune Response and Evasion Mechanisms ofJournal of immunology research · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Sebastian KirchnerWellcome Trust Centre for Molecular Parasitology, Institute of Infection, Immunity and Inflammation, College of Medical Veterinary & Life Sciences, University of Glasgow, Glasgow, G12 8TA, UK.
B Joanne PowerWellcome Trust Centre for Molecular Parasitology, Institute of Infection, Immunity and Inflammation, College of Medical Veterinary & Life Sciences, University of Glasgow, Glasgow, G12 8TA, UK.
Andrew P WatersWellcome Trust Centre for Molecular Parasitology, Institute of Infection, Immunity and Inflammation, College of Medical Veterinary & Life Sciences, University of Glasgow, Glasgow, G12 8TA, UK. AndyWaters@Glasgow.ac.uk.
University of Glasgow · GBWellcome Centre for Molecular Parasitology · GBWellcome Trust · GB

Funding

Wellcome Trust 083811
6 · The paper itself

Abstract

Malaria continues to impose a significant disease burden on low- and middle-income countries in the tropics. However, revolutionary progress over the last 3 years in nucleic acid sequencing, reverse genetics, and post-genome analyses has generated step changes in our understanding of malaria parasite (Plasmodium spp.) biology and its interactions with its host and vector. Driven by the availability of vast amounts of genome sequence data from Plasmodium species strains, relevant human populations of different ethnicities, and mosquito vectors, researchers can consider any biological component of the malarial process in isolation or in the interactive setting that is infection. In particular, considerable progress has been made in the area of population genomics, with Plasmodium falciparum serving as a highly relevant model. Such studies have demonstrated that genome evolution under strong selective pressure can be detected. These data, combined with reverse genetics, have enabled the identification of the region of the P. falciparum genome that is under selective pressure and the confirmation of the functionality of the mutations in the kelch13 gene that accompany resistance to the major frontline antimalarial, artemisinin. Furthermore, the central role of epigenetic regulation of gene expression and antigenic variation and developmental fate in P. falciparum is becoming ever clearer. This review summarizes recent exciting discoveries that genome technologies have enabled in malaria research and highlights some of their applications to healthcare. The knowledge gained will help to develop surveillance approaches for the emergence or spread of drug resistance and to identify new targets for the development of antimalarial drugs and perhaps vaccines.

Indexed as

Epigenesis, GeneticGenome, ProtozoanAnimalsAntimalarialsArtemisininsBiological EvolutionDrug ResistanceGenomicsHost-Parasite InteractionsHumansKelch RepeatMalaria, FalciparumMosquito VectorsPlasmodium falciparumProtozoan ProteinsReverse GeneticsAntimalarialsartemisininArtemisininsProtozoan Proteins

Identifiers

PMID27605022
PMCPMC5015228
OpenAlexW2515044144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.